Asia Pacific Needle-Free Injection Systems Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product (Fillable Needle-free Injectors and Prefilled Needle-free Injectors), Technology (Jet-Based Needle-free Injectors, Spring-Based Needle-free Injectors, Microarray Patch Injectors, and Others), Type (Liquid-Based Needle-free Injectors, Projectile-based Needle-free Injectors, and Powder-Based Needle-free Injectors), Usability (Disposable and Reusable), Site of Delivery (Subcutaneous Injectors, Intramuscular Injectors, and Intradermal Injectors), Application (Vaccine Delivery, Insulin Delivery, Oncology, Pain Management, Dermatology, and Others), and End User (Hospitals, Home Care Settings, Research Laboratories, Pharmaceutical & Biotechnological Companies, and Other End User)    

No. of Pages: 164    |    Report Code: BMIRE00027761    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Asia Pacific Needle-Free Injection Systems Market

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. Asia Pacific Needle-Free Injection Systems Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. Asia Pacific Needle-Free Injection Systems Market – Key Market Dynamics

5.1 Growth Drivers
5.2 Market Opportunities
5.3 Future Trends
5.4 Impact of Drivers and Restraints

6. Asia Pacific Needle-Free Injection Systems Market Regional Analysis

6.1 Asia Pacific Needle-Free Injection Systems Market Overview
6.2 Asia Pacific Needle-Free Injection Systems Market Revenue 2020-2028 (US$ Million)
6.3 Asia Pacific Needle-Free Injection Systems Market Forecast Analysis

7. Asia Pacific Needle-Free Injection Systems Market Analysis – by Product

7.1 Fillable Needle-free Injectors and Prefilled Needle-free Injectors
  • 7.1.1 Overview
  • 7.1.2 Fillable Needle-free Injectors and Prefilled Needle-free Injectors: Asia Pacific Needle-Free Injection Systems Market – Revenue and Forecast to 2031 (US$ Million)

8. Asia Pacific Needle-Free Injection Systems Market Analysis – by Technology

8.1 Jet-Based Needle-free Injectors
  • 8.1.1 Overview
  • 8.1.2 Jet-Based Needle-free Injectors: Asia Pacific Needle-Free Injection Systems Market – Revenue and Forecast to 2028 (US$ Million)
8.2 Spring-Based Needle-free Injectors
  • 8.2.1 Overview
  • 8.2.2 Spring-Based Needle-free Injectors: Asia Pacific Needle-Free Injection Systems Market – Revenue and Forecast to 2028 (US$ Million)
8.3 Microarray Patch Injectors
  • 8.3.1 Overview
  • 8.3.2 Microarray Patch Injectors: Asia Pacific Needle-Free Injection Systems Market – Revenue and Forecast to 2028 (US$ Million)

9. Asia Pacific Needle-Free Injection Systems Market Analysis – by Type

9.1 Liquid-Based Needle-free Injectors
  • 9.1.1 Overview
  • 9.1.2 Microarray Patch Injectors: Asia Pacific Needle-Free Injection Systems Market – Revenue and Forecast to 2028 (US$ Million)
9.2 Projectile-based Needle-free Injectors
  • 9.2.1 Overview
  • 9.2.2 Microarray Patch Injectors: Asia Pacific Needle-Free Injection Systems Market – Revenue and Forecast to 2028 (US$ Million)
9.3 Powder-Based Needle-free Injectors
  • 9.3.1 Overview
  • 9.3.2 Microarray Patch Injectors: Asia Pacific Needle-Free Injection Systems Market – Revenue and Forecast to 2028 (US$ Million)

10. Asia Pacific Needle-Free Injection Systems Market – Asia-Pacific Analysis

10.1 Asia-Pacific
  • 10.1.1 Asia Pacific Needle-Free Injection Systems Market Breakdown, by Key Country, 2023 and 2028 (%)
  • 10.1.1.1 Asia Pacific Needle-Free Injection Systems Market – Revenue and Forecast Analysis – by Country
  • 10.1.1.1 China: Asia Pacific Needle-Free Injection Systems Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.1.1 China: Asia Pacific Needle-Free Injection Systems Market Breakdown, by Product
    • 10.1.1.1.2 China: Asia Pacific Needle-Free Injection Systems Market Breakdown, by Technology
    • 10.1.1.1.3 China: Asia Pacific Needle-Free Injection Systems Market Breakdown, by Type
  • 10.1.1.2 India: Asia Pacific Needle-Free Injection Systems Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.2.1 India: Asia Pacific Needle-Free Injection Systems Market Breakdown, by Product
    • 10.1.1.2.2 India: Asia Pacific Needle-Free Injection Systems Market Breakdown, by Technology
    • 10.1.1.2.3 India: Asia Pacific Needle-Free Injection Systems Market Breakdown, by Type
  • 10.1.1.3 Japan: Asia Pacific Needle-Free Injection Systems Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.3.1 Japan: Asia Pacific Needle-Free Injection Systems Market Breakdown, by Product
    • 10.1.1.3.2 Japan: Asia Pacific Needle-Free Injection Systems Market Breakdown, by Technology
    • 10.1.1.3.3 Japan: Asia Pacific Needle-Free Injection Systems Market Breakdown, by Type
  • 10.1.1.4 Australia: Asia Pacific Needle-Free Injection Systems Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.4.1 Australia: Asia Pacific Needle-Free Injection Systems Market Breakdown, by Product
    • 10.1.1.4.2 Australia: Asia Pacific Needle-Free Injection Systems Market Breakdown, by Technology
    • 10.1.1.4.3 Australia: Asia Pacific Needle-Free Injection Systems Market Breakdown, by Type
  • 10.1.1.5 Rest of Asia-Pacific : Asia Pacific Needle-Free Injection Systems Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.5.1 Rest of Asia-Pacific : Asia Pacific Needle-Free Injection Systems Market Breakdown, by Product
    • 10.1.1.5.2 Rest of Asia-Pacific : Asia Pacific Needle-Free Injection Systems Market Breakdown, by Technology
    • 10.1.1.5.3 Rest of Asia-Pacific : Asia Pacific Needle-Free Injection Systems Market Breakdown, by Type

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. Asia Pacific Needle-Free Injection Systems Market Industry Landscape

12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Aijex Pharma International Inc.
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 Crossject
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 Ferring B.V.
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 Medical International Technologies (MIT Canada) Inc.
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 NuGen Medical Devices
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 Zealand Pharma A/S
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments

14. Appendix

14.1 About Business Market Insights

The List of Companies - Asia Pacific Needle-Free Injection Systems Market

  1. Aijex Pharma International Inc.
  2. Crossject
  3. Ferring B.V.
  4. Medical International Technologies (MIT Canada) Inc.
  5. NuGen Medical Devices
  6. Zealand Pharma A/S